Printer Friendly

IGI ANNOUNCES NEW NOVASOME PATENT

 BUENA, N.J., June 1 /PRNewswire/ -- IGI, Inc. (AMEX: IG) today reported that U.S. Patent No. 5,213,805 "Lipid Vesicles Having N, N Dimethylamide Derivatives as their Primary Lipid" has been issued by the U.S. Patent Office to one of its subsidiaries. This patent provides additional flexibility in the choices of building materials to make Novasome(R) Lipid Vesicles.
 "We are pleased the United States Patent Office has granted us yet another patent in our portfolio of Novasome applications. We believe it is in the best interest of our shareholders to continue to file patents in order to protect our technologies and their investment in IGI," the company said.
 N, N Dimethylamide derivatives, derived from soy and tall bean oils, are safe, inexpensive, easily biodegradable materials to use as encapsulants. These materials are used in industry and agriculture as diluents. Their main encapsulation applications thus far have been for chemicals such as biocides and paints. Their utility for foods, biologicals and pharmaceuticals has not yet been established.
 A total of 22 U.S. and 25 foreign patents covering MVS' Novasome and Ultrasponge technologies have issued to date. An additional 75 patents are pending at home and abroad.
 IGI is a diversified company engaged in the development, production and marketing of animal care products, cosmetics, consumer products and human pharmaceuticals.
 -0- 6/1/93
 /CONTACT: Michael Dodge of IGI, 609-697-1441, or Steven Bruce or Rick Stockton of Abernathy/MacGregor/Scanlon, 212-371-5999, for IGI/
 (IG)


CO: IGI, Inc. ST: New Jersey IN: MTC SU:

CK -- NY024 -- 3853 06/01/93 10:17 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 1, 1993
Words:264
Previous Article:THE ZWEIG TOTAL RETURN FUND, INC. DECLARES MONTHLY DISTRIBUTION
Next Article:RADIO CONSULTING RESEARCH PARTNERSHIP ANNOUNCED BY THE GALLUP ORGANIZATION AND VALLIE CONSULTING; FIRST-EVER IN RADIO INDUSTRY
Topics:


Related Articles
IGI THIRD QUARTER REVENUE SIGNIFICANTLY HIGHER; ADVANCES CITED IN LIPOSOME DEVELOPMENTS ON SEVERAL FRONTS
IGI 1991 REVENUE UP 10 PERCENT; ADVANCES CITED IN LIPOSOME DEVELOPMENTS
IGI COMMENTS ON BARRON'S ARTICLE
IGI UNIT AND UNGERER TO DEVELOP ENCAPSULATED FLAVORS
IGI LAUNCHES NEW CONSUMER PET CARE SYSTEM WITH VANNA WHITE
SECOND QUARTER REVENUES UP 12 PERCENT OVER 1991
SMITHKLINE BEECHAM AND IGI ANNOUNCE VACCINE PACT
IGI RECEIVES IRS APPROVAL OF SPINOFF PLANS
IGI INC. REPORTS FIRST QUARTER RESULTS; NET INCOME UP 98%
IGI, Inc. and Image Enhancing Dermatology to Launch New Product Line

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters